TrialPanorama/TrialPanorama-database huggingface dataset:
Study 34105207 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35747502 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35747502 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32013946 — Predictive Biomarker (PRD): EBF1 mRNA
Genes: EBF1; COE1; EBF
Study 33951124 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CSPG4 mRNA
Genes: CSPG4; MCSP
Study 32306008 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35606883 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 33533487 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33533487 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 32141389 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36460046 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 35690655 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35690655 — Surrogate Endpoint (SUR): Blood pressure
Study 35887829 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 33065163 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 36259475 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study 36259475 — Safety Biomarker (SAF): Reactive oxygen species
Study 36259475 — Surrogate Endpoint (SUR): Blood pressure
Study 33663735 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 33663735 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32710391 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32860031 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study 32860031 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33837592 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32152347 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 36423855 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 36423855 — Surrogate Endpoint (SUR): Bone mineral density
Study 32949027 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 32949027 — Predictive Biomarker (PRD): NDUFB8 mRNA
Genes: NDUFB8
Study 34848133 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 35129040 — Surrogate Endpoint (SUR): Serum testosterone
Study 36060828 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32158015 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 32158015 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 33079180 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33079180 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33079180 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 33079180 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35862871 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 32389020 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 33522396 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35135619 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 33043600 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32682482 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32687564 — Surrogate Endpoint (SUR): Blood pressure
Study 33377958 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33377958 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32531762 — Predictive Biomarker (PRD): SLC5A8 mRNA
Genes: SLC5A8; AIT; SMCT; SMCT1
Study 34590561 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34590561 — Monitoring Biomarker (MOI): Procalcitonin
Study 34590561 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34590561 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34982098 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 32131802 — Surrogate Endpoint (SUR): Blood pressure
Study 35698100 — Surrogate Endpoint (SUR): Pathological complete response
Study 32144133 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32144133 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35171190 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34931480 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35667914 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35285940 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32586268 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 32586268 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 34728062 — Surrogate Endpoint (SUR): Serum potassium
Study 35986353 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 35986353 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35986353 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35986353 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 35986353 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 35986353 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35986353 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 35986353 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 35986353 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 32988369 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32988369 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 32988369 — Surrogate Endpoint (SUR): Blood pressure
Study 35379296 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32381562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34852764 — Surrogate Endpoint (SUR): Blood pressure
Study 35753841 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33457089 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 33171172 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 33607806 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 32623487 — Surrogate Endpoint (SUR): Bone mineral density
Study 35186243 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35186243 — Predictive Biomarker (PRD): STIL mRNA
Genes: STIL; SIL
Study 35186243 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 32448110 — Surrogate Endpoint (SUR): Blood pressure
Study 32448110 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34266319 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 34266319 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study 34039693 — Surrogate Endpoint (SUR): Blood pressure
Study 35168030 — Surrogate Endpoint (SUR): Blood pressure
Study 32728879 — Surrogate Endpoint (SUR): Blood pressure
Study 33857946 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study 32812320 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 34579049 — Surrogate Endpoint (SUR): Bacterial count
Study 33914256 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 35428320 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 32772617 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study 37002653 — Predictive Biomarker (PRD): PAG1 mRNA
Genes: PAG1; CBP; PAG
Study 32979921 — Surrogate Endpoint (SUR): Blood pressure
Study 32979921 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 32767712 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 34230452 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 33620233 — Predictive Biomarker (PRD): ADIPOQ mRNA
Genes: ADIPOQ; ACDC; ACRP30; APM1; GBP28
Study 35028950 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 32054355 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 33983396 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 34534488 — Surrogate Endpoint (SUR): Blood pressure
Study 34534488 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33862582 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33862582 — Predictive Biomarker (PRD): SMAD4 mRNA
Genes: SMAD4; DPC4; MADH4
Study 33647393 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 33647393 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 33647393 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 33647393 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Chitinase-3-like protein 1
Genes: CHI3L1
Study 33647393 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 32039689 — Surrogate Endpoint (SUR): Blood pressure
Study 32608134 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32608134 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32608134 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 32608134 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34456194 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 34456194 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study 33560444 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 33560444 — Safety Biomarker (SAF): BDNF
Study 37258803 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32338946 — Predictive Biomarker (PRD): GSR mRNA
Genes: GSR; GLUR; GRD1
Study 35449097 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study 36111858 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35679826 — Surrogate Endpoint (SUR): Blood pressure
Study 35947288 — Predictive Biomarker (PRD): BAG3 mRNA
Genes: BAG3; BIS
Study 36115850 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33752252 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 34328440 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 35278283 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 35310181 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34293081 — Predictive Biomarker (PRD): AMY1A mRNA
Genes: AMY1A; AMY1
Study 34293081 — Predictive Biomarker (PRD): AMY2A mRNA
Genes: AMY2A
Study 34293081 — Predictive Biomarker (PRD): AMY2B mRNA
Genes: AMY2B
Study 34293081 — Predictive Biomarker (PRD): MGAM mRNA
Genes: MGAM; MGA; MGAML
Study 34293081 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 34357466 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 34357466 — Surrogate Endpoint (SUR): Serum creatinine
Study 32281641 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 34691303 — Surrogate Endpoint (SUR): Serum creatinine
Study 35339004 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 34058114 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 36350802 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36350802 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36350802 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 36358943 — Surrogate Endpoint (SUR): Blood pressure
Study 32471143 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 33599356 — Predictive Biomarker (PRD): CX3CL1 mRNA
Genes: CX3CL1; FKN; NTT; SCYD1; A-152E5.2
Study 33599356 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33248978 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 34537912 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33632926 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 32102119 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study 32214382 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 33671310 — Surrogate Endpoint (SUR): Blood pressure
Study 33671310 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 35468322 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 32440938 — Surrogate Endpoint (SUR): Blood pressure
Study 36308079 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 36308079 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study 36308079 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study 36308079 — Safety Biomarker (SAF): Reactive oxygen species
Study 33302802 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 33302802 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33302802 — Surrogate Endpoint (SUR): Blood pressure
Study 36328040 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 34416295 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34416295 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34416295 — Safety Biomarker (SAF): IL-6 and IL-10
Study 34210325 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33314690 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 32703769 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 34380638 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34380638 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33441146 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 32209798 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32209798 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33187020 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 32496449 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32898569 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 32898569 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 32898569 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32898569 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study 32898569 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 32898569 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study 32898569 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 32536013 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32536013 — Predictive Biomarker (PRD): Hormone receptor
Study 35086385 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 32272973 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35853489 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 36367998 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33432386 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 34666767 — Safety Biomarker (SAF): Hyaluronic acid
Study 34266940 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 35623315 — Predictive Biomarker (PRD): PPARGC1B mRNA
Genes: PPARGC1B; PERC; PGC1; PGC1B; PPARGC1
Study 33586134 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 33731525 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 32474156 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 32474156 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 33546734 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 33546734 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33546734 — Surrogate Endpoint (SUR): Serum creatinine
Study 34580114 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 35450055 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35450055 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35450055 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32505932 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study 33819166 — Surrogate Endpoint (SUR): Blood pressure
Study 32624405 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 35784687 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35784687 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 35784687 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33031171 — Surrogate Endpoint (SUR): Blood pressure
Study 35126900 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 35126900 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 35126900 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33031833 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 33031833 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 33031833 — Surrogate Endpoint (SUR): Serum creatinine
Study 34590804 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 34470722 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 32349927 — Surrogate Endpoint (SUR): Serum testosterone
Study 35635482 — Surrogate Endpoint (SUR): Blood pressure
Study 32937598 — Surrogate Endpoint (SUR): Blood pressure
Study 35584475 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35584475 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34228837 — Predictive Biomarker (PRD): COL3A1 mRNA
Genes: COL3A1
Study 34228837 — Predictive Biomarker (PRD): COL4A1 mRNA
Genes: COL4A1
Study 34486739 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study 32077402 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 33888595 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32485294 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32485294 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35241087 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 35241087 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 34465357 — Surrogate Endpoint (SUR): Blood pressure
Study 34787778 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32970697 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 32179010 — Predictive Biomarker (PRD): STC1 mRNA
Genes: STC1; STC
Study 34002557 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 36125566 — Surrogate Endpoint (SUR): Bone mineral density
Study 35442766 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33825892 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study 34601896 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 34601896 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 34601896 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 34601896 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36484441 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33887722 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33887722 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 35377919 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 34365061 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34365061 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 34365061 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34365061 — Safety Biomarker (SAF): IL-6 and IL-10
Study 32859661 — Surrogate Endpoint (SUR): Blood pressure
Study 33333526 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 32575124 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34496276 — Surrogate Endpoint (SUR): Blood pressure
Study 34496276 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32220517 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF